Table 1.
Demographics, clinical characteristics, and subclinical vascular indices of RA patients.
| RA patients (n = 85) | ||
|---|---|---|
| Age (years) | 59.2 ± 12.5 | |
| Gender (male) (%) | 15.3 | |
| BMI (kgs/m2) | 27.0 ± 4.8 | |
| DAS 28 | 2.45 ± 0.92 | |
| Biologic therapy (n) | 36.5 | |
| C-reactive protein (mg/L) | 3.2 (3.2–6.0) | |
| Systolic BP (mmHg) | 124.8 ± 18.5 | |
| Diastolic BP (mmHg) | 74.4 ± 7.0 | |
| Map (mmHg) | 87.4 ± 9.9 | |
| Smoking (%) | Never | 44.7 |
| Current | 21.2 | |
| Ex | 34.1 | |
| Hypertension (%) (after reclassification)* | 40 | |
| Hyperlipidemia (%) (after reclassification)** | 40.5 | |
| Antihypertensive drugs (%) | 35.3 | |
| Lipid lowering drugs (%) | – | |
| Plaques (%) | Carotid and/or femoral | 42.4 |
| Carotid | 36.5 | |
| Femoral | 35.3 | |
| IMT (mm) | RCCA | 0.692 ± 0.133 |
| LCCA | 0.741 ± 0.155 | |
| PWV (m/s) | 8.45 ± 1.84 | |
| AIx@75 (%) | 32.4 ± 10.6 | |
*
YES if already treated or based on out-of-office BP measurements.
**
YES if reported to be diagnosed in the past or (b) diagnosed if LDL measurement >130 mg/dl.
Data are mean ± SD.